Net Loss of Sterling Biotech reported to Rs 96.10 crore in the quarter ended March 2013 as against net loss of Rs 92.15 crore during the previous quarter ended March 2012. Sales declined 0.85% to Rs 205.76 crore in the quarter ended March 2013 as against Rs 207.52 crore during the previous quarter ended March 2012.
ParticularsQuarter EndedMar. 2013Mar. 2012% Var.Sales205.76207.52 -1 OPM %12.9214.90 -13 PBDT-78.92-72.78 -8 PBT-142.26-136.40 -4 NP-96.10-92.15 -4
Powered by Capital Market - Live News
